RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Metformin Doses Not Reduce Heart Failure after STEMI in Patients without Diabetes (GIPS-III)
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 4
SP 24
OP 25
DO 10.1177/155989771404014
UL http://mdc.sagepub.com/content/14/4/24.abstract
AB Results of a double-blind, randomized, placebo-controlled, parallel-group trial do not support the routine use of metformin in nondiabetic patients after ST-segment elevation myocardial infarction (STEMI) for the purpose of preserving myocardial function. Findings of the Metformin to Reduce Heart Failure After Myocardial Infarction trial [GIPS-III; Lexis CPH et al. JAMA 2014] are discussed in this article.